Clinical trial
Study of FK463 for the Treatment of Invasive Aspergillosis
NCT00036166 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00036166 |
|---|---|
| Title | Study of FK463 for the Treatment of Invasive Aspergillosis |
| Official title | An Open-Label, Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Aspergillosis |
| Intervention type | Drug |
| Interventions | FK463 |
| Enrollment | 326 |
| Start date | Jan 29, 1999 |
| Primary completion | Jan 31, 2002 |
| Completion | Jan 31, 2002 |
| First posted | May 9, 2002 |
| Last update posted | Jan 10, 2018 |
| Countries | Austria, France, Germany, Italy, Poland, Spain, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: